REGN icon

Regeneron Pharmaceuticals

618 hedge funds and large institutions have $24.9B invested in Regeneron Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 222 increasing their positions, 211 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

7% less capital invested

Capital invested by funds: $26.9B → $24.9B (-$1.94B)

14% less first-time investments, than exits

New positions opened: 83 | Existing positions closed: 97

31% less call options, than puts

Call options by funds: $594M | Put options by funds: $861M

Holders
618
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$594M
Puts
$861M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$225M
27
$221M
28
$216M
29
$215M
30
$205M
31
$170M
32
$166M
33
$157M
34
$152M
35
$126M
36
$120M
37
$117M
38
$107M
39
$102M
40
$102M
41
$100M
42
$98.3M
43
$96.4M
44
$96M
45
$93.4M
46
$87.4M
47
$83M
48
$77.7M
49
$77M
50
$75.9M